Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Tony Shock

Tony Shock

Director of UCB
UCB Pharma
United Kingdom

Biography

Anthony Shock received his PhD in Biochemistry from the University of London in 1987 followed by post-doctoral work at the National Heart & Lung Institute in London. He was then employed by a Biotech company called Celltech which eventually transformed into the global biopharmaceutical company, UCB. He has researched on a wide range of drug targets, both small molecule- and antibody-based therapies, including two antibody targets that have been evaluated in patients with systemic lupus erythematosus, namely epratuzumab and dapirolizumab pegol.

Research Interest

Autoimmunity; monoclonal antibodies; lupus; immunology.